ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mebendazole Tablet Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23K18327
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Mebendazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Mebendazole Tablet Market Research Report 2025

Code: QYRE-Auto-23K18327
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Wellona Pharma
ARPIMED
AdvaCare
Anhui Medipharm
SPMC
Nestor
LEXICARE PHARMA
NOUVASANT

Mebendazole Tablet Market

The global market for Mebendazole Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mebendazole Tablets are indicated for the treatment of pinworms, roundworms, whipworms, hookworms, strongyloides sterculoides and tapeworms alone or in combination.
North American market for Mebendazole Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mebendazole Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mebendazole Tablet include Johnson & Johnson, Wellona Pharma, Arpimed, AdvaCare, Anhui Medipharm, SPMC, NESTOR, LEXICARE PHARMA, NOUVASANT, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mebendazole Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole Tablet.
The Mebendazole Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mebendazole Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mebendazole Tablet Market Report

Report Metric Details
Report Name Mebendazole Tablet Market
Segment by Type
  • 100mg
  • 500mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Wellona Pharma, Arpimed, AdvaCare, Anhui Medipharm, SPMC, NESTOR, LEXICARE PHARMA, NOUVASANT
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mebendazole Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mebendazole Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mebendazole Tablet Market report?

Ans: The main players in the Mebendazole Tablet Market are Johnson & Johnson, Wellona Pharma, Arpimed, AdvaCare, Anhui Medipharm, SPMC, NESTOR, LEXICARE PHARMA, NOUVASANT

What are the Application segmentation covered in the Mebendazole Tablet Market report?

Ans: The Applications covered in the Mebendazole Tablet Market report are Threadworm Infection, Pinworm Infection, Whipworm Infection, Others

What are the Type segmentation covered in the Mebendazole Tablet Market report?

Ans: The Types covered in the Mebendazole Tablet Market report are 100mg, 500mg

Recommended Reports

Anthelmintic and Antiparasitics

Tablet Formulations

Veterinary Deworming

1 Mebendazole Tablet Market Overview
1.1 Product Definition
1.2 Mebendazole Tablet by Type
1.2.1 Global Mebendazole Tablet Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg
1.2.3 500mg
1.3 Mebendazole Tablet by Application
1.3.1 Global Mebendazole Tablet Market Value by Application (2024 VS 2031)
1.3.2 Threadworm Infection
1.3.3 Pinworm Infection
1.3.4 Whipworm Infection
1.3.5 Others
1.4 Global Mebendazole Tablet Market Size Estimates and Forecasts
1.4.1 Global Mebendazole Tablet Revenue 2020-2031
1.4.2 Global Mebendazole Tablet Sales 2020-2031
1.4.3 Global Mebendazole Tablet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mebendazole Tablet Market Competition by Manufacturers
2.1 Global Mebendazole Tablet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mebendazole Tablet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mebendazole Tablet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mebendazole Tablet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mebendazole Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mebendazole Tablet, Product Type & Application
2.7 Global Key Manufacturers of Mebendazole Tablet, Date of Enter into This Industry
2.8 Global Mebendazole Tablet Market Competitive Situation and Trends
2.8.1 Global Mebendazole Tablet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mebendazole Tablet Players Market Share by Revenue
2.8.3 Global Mebendazole Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mebendazole Tablet Market Scenario by Region
3.1 Global Mebendazole Tablet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mebendazole Tablet Sales by Region: 2020-2031
3.2.1 Global Mebendazole Tablet Sales by Region: 2020-2025
3.2.2 Global Mebendazole Tablet Sales by Region: 2026-2031
3.3 Global Mebendazole Tablet Revenue by Region: 2020-2031
3.3.1 Global Mebendazole Tablet Revenue by Region: 2020-2025
3.3.2 Global Mebendazole Tablet Revenue by Region: 2026-2031
3.4 North America Mebendazole Tablet Market Facts & Figures by Country
3.4.1 North America Mebendazole Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mebendazole Tablet Sales by Country (2020-2031)
3.4.3 North America Mebendazole Tablet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mebendazole Tablet Market Facts & Figures by Country
3.5.1 Europe Mebendazole Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mebendazole Tablet Sales by Country (2020-2031)
3.5.3 Europe Mebendazole Tablet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mebendazole Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Mebendazole Tablet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mebendazole Tablet Sales by Region (2020-2031)
3.6.3 Asia Pacific Mebendazole Tablet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mebendazole Tablet Market Facts & Figures by Country
3.7.1 Latin America Mebendazole Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mebendazole Tablet Sales by Country (2020-2031)
3.7.3 Latin America Mebendazole Tablet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mebendazole Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Mebendazole Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mebendazole Tablet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mebendazole Tablet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mebendazole Tablet Sales by Type (2020-2031)
4.1.1 Global Mebendazole Tablet Sales by Type (2020-2025)
4.1.2 Global Mebendazole Tablet Sales by Type (2026-2031)
4.1.3 Global Mebendazole Tablet Sales Market Share by Type (2020-2031)
4.2 Global Mebendazole Tablet Revenue by Type (2020-2031)
4.2.1 Global Mebendazole Tablet Revenue by Type (2020-2025)
4.2.2 Global Mebendazole Tablet Revenue by Type (2026-2031)
4.2.3 Global Mebendazole Tablet Revenue Market Share by Type (2020-2031)
4.3 Global Mebendazole Tablet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mebendazole Tablet Sales by Application (2020-2031)
5.1.1 Global Mebendazole Tablet Sales by Application (2020-2025)
5.1.2 Global Mebendazole Tablet Sales by Application (2026-2031)
5.1.3 Global Mebendazole Tablet Sales Market Share by Application (2020-2031)
5.2 Global Mebendazole Tablet Revenue by Application (2020-2031)
5.2.1 Global Mebendazole Tablet Revenue by Application (2020-2025)
5.2.2 Global Mebendazole Tablet Revenue by Application (2026-2031)
5.2.3 Global Mebendazole Tablet Revenue Market Share by Application (2020-2031)
5.3 Global Mebendazole Tablet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Mebendazole Tablet Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Wellona Pharma
6.2.1 Wellona Pharma Company Information
6.2.2 Wellona Pharma Description and Business Overview
6.2.3 Wellona Pharma Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Wellona Pharma Mebendazole Tablet Product Portfolio
6.2.5 Wellona Pharma Recent Developments/Updates
6.3 Arpimed
6.3.1 Arpimed Company Information
6.3.2 Arpimed Description and Business Overview
6.3.3 Arpimed Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Arpimed Mebendazole Tablet Product Portfolio
6.3.5 Arpimed Recent Developments/Updates
6.4 AdvaCare
6.4.1 AdvaCare Company Information
6.4.2 AdvaCare Description and Business Overview
6.4.3 AdvaCare Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AdvaCare Mebendazole Tablet Product Portfolio
6.4.5 AdvaCare Recent Developments/Updates
6.5 Anhui Medipharm
6.5.1 Anhui Medipharm Company Information
6.5.2 Anhui Medipharm Description and Business Overview
6.5.3 Anhui Medipharm Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Anhui Medipharm Mebendazole Tablet Product Portfolio
6.5.5 Anhui Medipharm Recent Developments/Updates
6.6 SPMC
6.6.1 SPMC Company Information
6.6.2 SPMC Description and Business Overview
6.6.3 SPMC Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SPMC Mebendazole Tablet Product Portfolio
6.6.5 SPMC Recent Developments/Updates
6.7 NESTOR
6.7.1 NESTOR Company Information
6.7.2 NESTOR Description and Business Overview
6.7.3 NESTOR Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NESTOR Mebendazole Tablet Product Portfolio
6.7.5 NESTOR Recent Developments/Updates
6.8 LEXICARE PHARMA
6.8.1 LEXICARE PHARMA Company Information
6.8.2 LEXICARE PHARMA Description and Business Overview
6.8.3 LEXICARE PHARMA Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LEXICARE PHARMA Mebendazole Tablet Product Portfolio
6.8.5 LEXICARE PHARMA Recent Developments/Updates
6.9 NOUVASANT
6.9.1 NOUVASANT Company Information
6.9.2 NOUVASANT Description and Business Overview
6.9.3 NOUVASANT Mebendazole Tablet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NOUVASANT Mebendazole Tablet Product Portfolio
6.9.5 NOUVASANT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mebendazole Tablet Industry Chain Analysis
7.2 Mebendazole Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mebendazole Tablet Production Mode & Process Analysis
7.4 Mebendazole Tablet Sales and Marketing
7.4.1 Mebendazole Tablet Sales Channels
7.4.2 Mebendazole Tablet Distributors
7.5 Mebendazole Tablet Customer Analysis
8 Mebendazole Tablet Market Dynamics
8.1 Mebendazole Tablet Industry Trends
8.2 Mebendazole Tablet Market Drivers
8.3 Mebendazole Tablet Market Challenges
8.4 Mebendazole Tablet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Wellona Pharma
ARPIMED
AdvaCare
Anhui Medipharm
SPMC
Nestor
LEXICARE PHARMA
NOUVASANT
List of Tables
 Table 1. Global Mebendazole Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mebendazole Tablet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mebendazole Tablet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mebendazole Tablet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mebendazole Tablet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mebendazole Tablet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mebendazole Tablet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mebendazole Tablet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mebendazole Tablet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mebendazole Tablet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mebendazole Tablet, Product Type & Application
 Table 12. Global Key Manufacturers of Mebendazole Tablet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mebendazole Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebendazole Tablet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mebendazole Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mebendazole Tablet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mebendazole Tablet Sales Market Share by Region (2020-2025)
 Table 19. Global Mebendazole Tablet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mebendazole Tablet Sales Market Share by Region (2026-2031)
 Table 21. Global Mebendazole Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mebendazole Tablet Revenue Market Share by Region (2020-2025)
 Table 23. Global Mebendazole Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mebendazole Tablet Revenue Market Share by Region (2026-2031)
 Table 25. North America Mebendazole Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mebendazole Tablet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mebendazole Tablet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mebendazole Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mebendazole Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mebendazole Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mebendazole Tablet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mebendazole Tablet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mebendazole Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mebendazole Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mebendazole Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mebendazole Tablet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mebendazole Tablet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mebendazole Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mebendazole Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mebendazole Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mebendazole Tablet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mebendazole Tablet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mebendazole Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mebendazole Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mebendazole Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mebendazole Tablet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mebendazole Tablet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mebendazole Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mebendazole Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mebendazole Tablet Sales (K Units) by Type (2020-2025)
 Table 51. Global Mebendazole Tablet Sales (K Units) by Type (2026-2031)
 Table 52. Global Mebendazole Tablet Sales Market Share by Type (2020-2025)
 Table 53. Global Mebendazole Tablet Sales Market Share by Type (2026-2031)
 Table 54. Global Mebendazole Tablet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mebendazole Tablet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mebendazole Tablet Revenue Market Share by Type (2020-2025)
 Table 57. Global Mebendazole Tablet Revenue Market Share by Type (2026-2031)
 Table 58. Global Mebendazole Tablet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mebendazole Tablet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mebendazole Tablet Sales (K Units) by Application (2020-2025)
 Table 61. Global Mebendazole Tablet Sales (K Units) by Application (2026-2031)
 Table 62. Global Mebendazole Tablet Sales Market Share by Application (2020-2025)
 Table 63. Global Mebendazole Tablet Sales Market Share by Application (2026-2031)
 Table 64. Global Mebendazole Tablet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mebendazole Tablet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mebendazole Tablet Revenue Market Share by Application (2020-2025)
 Table 67. Global Mebendazole Tablet Revenue Market Share by Application (2026-2031)
 Table 68. Global Mebendazole Tablet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mebendazole Tablet Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Mebendazole Tablet Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Wellona Pharma Company Information
 Table 76. Wellona Pharma Description and Business Overview
 Table 77. Wellona Pharma Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Wellona Pharma Mebendazole Tablet Product
 Table 79. Wellona Pharma Recent Developments/Updates
 Table 80. Arpimed Company Information
 Table 81. Arpimed Description and Business Overview
 Table 82. Arpimed Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Arpimed Mebendazole Tablet Product
 Table 84. Arpimed Recent Developments/Updates
 Table 85. AdvaCare Company Information
 Table 86. AdvaCare Description and Business Overview
 Table 87. AdvaCare Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AdvaCare Mebendazole Tablet Product
 Table 89. AdvaCare Recent Developments/Updates
 Table 90. Anhui Medipharm Company Information
 Table 91. Anhui Medipharm Description and Business Overview
 Table 92. Anhui Medipharm Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Anhui Medipharm Mebendazole Tablet Product
 Table 94. Anhui Medipharm Recent Developments/Updates
 Table 95. SPMC Company Information
 Table 96. SPMC Description and Business Overview
 Table 97. SPMC Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. SPMC Mebendazole Tablet Product
 Table 99. SPMC Recent Developments/Updates
 Table 100. NESTOR Company Information
 Table 101. NESTOR Description and Business Overview
 Table 102. NESTOR Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. NESTOR Mebendazole Tablet Product
 Table 104. NESTOR Recent Developments/Updates
 Table 105. LEXICARE PHARMA Company Information
 Table 106. LEXICARE PHARMA Description and Business Overview
 Table 107. LEXICARE PHARMA Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. LEXICARE PHARMA Mebendazole Tablet Product
 Table 109. LEXICARE PHARMA Recent Developments/Updates
 Table 110. NOUVASANT Company Information
 Table 111. NOUVASANT Description and Business Overview
 Table 112. NOUVASANT Mebendazole Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. NOUVASANT Mebendazole Tablet Product
 Table 114. NOUVASANT Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Mebendazole Tablet Distributors List
 Table 118. Mebendazole Tablet Customers List
 Table 119. Mebendazole Tablet Market Trends
 Table 120. Mebendazole Tablet Market Drivers
 Table 121. Mebendazole Tablet Market Challenges
 Table 122. Mebendazole Tablet Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mebendazole Tablet
 Figure 2. Global Mebendazole Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mebendazole Tablet Market Share by Type: 2024 & 2031
 Figure 4. 100mg Product Picture
 Figure 5. 500mg Product Picture
 Figure 6. Global Mebendazole Tablet Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Mebendazole Tablet Market Share by Application: 2024 & 2031
 Figure 8. Threadworm Infection
 Figure 9. Pinworm Infection
 Figure 10. Whipworm Infection
 Figure 11. Others
 Figure 12. Global Mebendazole Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Mebendazole Tablet Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Mebendazole Tablet Sales (2020-2031) & (K Units)
 Figure 15. Global Mebendazole Tablet Average Price (US$/Unit) & (2020-2031)
 Figure 16. Mebendazole Tablet Report Years Considered
 Figure 17. Mebendazole Tablet Sales Share by Manufacturers in 2024
 Figure 18. Global Mebendazole Tablet Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Mebendazole Tablet Players: Market Share by Revenue in Mebendazole Tablet in 2024
 Figure 20. Mebendazole Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Mebendazole Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Mebendazole Tablet Sales Market Share by Country (2020-2031)
 Figure 23. North America Mebendazole Tablet Revenue Market Share by Country (2020-2031)
 Figure 24. United States Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Mebendazole Tablet Sales Market Share by Country (2020-2031)
 Figure 27. Europe Mebendazole Tablet Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Mebendazole Tablet Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Mebendazole Tablet Revenue Market Share by Region (2020-2031)
 Figure 35. China Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Mebendazole Tablet Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Mebendazole Tablet Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Mebendazole Tablet Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Mebendazole Tablet Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Mebendazole Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Mebendazole Tablet by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Mebendazole Tablet by Type (2020-2031)
 Figure 54. Global Mebendazole Tablet Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Mebendazole Tablet by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Mebendazole Tablet by Application (2020-2031)
 Figure 57. Global Mebendazole Tablet Price (US$/Unit) by Application (2020-2031)
 Figure 58. Mebendazole Tablet Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Albendazole Tablets Market Research Report 2024
Albendazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mebendazole Market Research Report 2024
Albendazole Anthelmintic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vermox Market Research Report 2024
Global Anthelmintic Fenbendazole Market Research Report 2024
Global Tinidazole Tablet Market Insights Forecast to 2030
Global Oxfendazole Market Research Report 2024
Global Albendazole and Lvermectin Market Research Report 2024
Global Ricobendazole Market Research Report 2024
Ivermectin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ornidazole Tablets Market Research Report 2024
Global Flubendazole Market Research Report 2024
Anti worm Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Triclabendazole Market Research Report 2024
Albendazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albendazole Bolus Market Research Report 2024
Global Anti helminthic Drugs Market Research Report 2024
Global Companion Animal Anthelmintics Market Research Report 2024
Global Ivermectin for Human Market Insights Forecast to 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions